Data / Form D filings / Taxus Pharmaceuticals, Inc.
Taxus Pharmaceuticals, Inc.: Form D filing
Taxus Pharmaceuticals, Inc., a pharmaceuticals company in Jinzhong, China, filed a Form D with the SEC in 2012. The latest, on May 10, 2012, reports $3,620 sold of a $3,620 offering to 35 investors.
Find out what Taxus Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ROOM 1202, 12TH FLOOR, JIN SHANG INTERNATIONAL GOLDEN TOWER, Jinzhong, China, 03060
- Phone
- 863543366761
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2012
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 505
- SEC identifier (CIK)
- 1549065
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 10, 2012 | New notice | $3,620 | $3,620 | $0 | 35 | Mar 22, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jiayue Zhang | Executive Officer, Director | |
| Zhixin Li | Director | |
| Tong Zhang | Executive Officer, Director | |
| Xiaoxing Zhang | Executive Officer, Director | |
| Hong Zhang | Director |
Every Form D from the week of May 7, 2012 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Taxus Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.